[EN] PHENYLSULFONAMIDO-BENZOFURAN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF PROLIFERATIVE DISEASES<br/>[FR] DÉRIVÉS PHÉNYLSULFONAMIDO-BENZOFURANE ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES PROLIFÉRATIVES
申请人:MEMORIAL SLOAN KETTERING CANCER CENTER
公开号:WO2017027845A1
公开(公告)日:2017-02-16
Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.
本文描述了苯磺酰胺基苯并呋喃衍生物及其药学上可接受的盐。还提供了涉及式(I)、(II)、(III)、(IV)、(V)或(VI)化合物的制药组合物、方法、用途和工具包,用于治疗和/或预防受试者的增生性疾病(例如癌症、炎症性疾病和自身免疫性疾病)。本文所述的化合物和制药组合物在生物样品或受试者中抑制BCL-2家族中的至少一种蛋白质,以治疗和/或预防增生性疾病。在某些实施例中,本文所述化合物是MCL-1的选择性抑制剂,MCL-1是BCL-2家族成员蛋白质之一。